当前位置:Public Access >页面
Chinese/English
A Multicenter, Single-Arm, Open-Label Clinical Study of Cetuximab Beta in Combination with Pucotenlimab and Chemotherapy as Neoadjuvant Therapy for KRAS/NRAS Wild-Type Left-Sided Colon Cancer and Upper Rectal Cance
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。